Celeste Murphy, Legal Branch Chief
Office of Life Sciences
Division of Corporate Finance
United States Securities and Exchange Commission
Washington, D.C. 20549
March 5, 2020
Re: | Quadrant Biosciences Inc. | |
Offering Statement on Form 1-A | ||
File No. 024-11155 |
Dear Ms. Murphy,
On behalf of Quadrant Biosciences Inc., I hereby request qualification of the above-referenced offering statement at 4pm Eastern time March 9, 2020, or as soon thereafter as is practicable.
Sincerely,
/s/ Richard Uhlig
Richard Uhlig
Chief Executive Officer
Quadrant Biosciences Inc.